Offit, Kenneth

Publications

Sort by

Co-Author Network

selected publications

Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test. Public health genomics. 2020 Academic Article GET IT
Times cited: 9
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2020 Academic Article GET IT
Times cited: 24
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nature communications. 2020 Academic Article GET IT
Times cited: 385
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 74
Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 57
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature genetics. 2020 Academic Article GET IT
Times cited: 119
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes. 2020 GET IT
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Gastroenterology. 2019 Academic Article GET IT
Times cited: 100
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer. Gastroenterology. 2019 Academic Article GET IT
Times cited: 133
Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2019 Academic Article GET IT
Times cited: 30
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma. Human mutation. 2019 Academic Article GET IT
Times cited: 32
Tumour lineage shapes BRCA-mediated phenotypes. Nature. 2019 Academic Article GET IT
Times cited: 306
Toward automation of germline variant curation in clinical cancer genetics. Genetics in medicine : official journal of the American College of Medical Genetics. 2019 Academic Article GET IT
Times cited: 30
Novel Common Genetic Susceptibility Loci for Colorectal Cancer. Journal of the National Cancer Institute. 2019 Academic Article GET IT
Times cited: 123
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American journal of human genetics. 2018 Academic Article GET IT
Times cited: 713
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 443
High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation. Human genetics. 2018 Academic Article GET IT
Times cited: 18
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer research. 2018 Academic Article GET IT
Times cited: 68
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature genetics. 2017 Academic Article GET IT
Times cited: 289
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. JAMA. 2017 Academic Article GET IT
Times cited: 390
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute. 2017 Academic Article GET IT
Times cited: 230
Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling. Journal of oncology practice. 2017 Academic Article GET IT
Times cited: 29
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature genetics. 2017 Academic Article GET IT
Times cited: 335
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Cancer. 2017 Academic Article GET IT
Times cited: 8
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nature communications. 2017 Academic Article GET IT
Times cited: 72
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European journal of human genetics : EJHG. 2017 Academic Article GET IT
Times cited: 28
Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 14
Reply to R.L. Nussbaum et al and J.S. Dolinsky et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Article GET IT
Times cited: 1
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast cancer research : BCR. 2016 Academic Article GET IT
Times cited: 52
DNA-Repair Gene Mutations in Metastatic Prostate Cancer. The New England journal of medicine. 2016 Article GET IT
Times cited: 2
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. JAMA oncology. 2016 Academic Article GET IT
Times cited: 202
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast cancer research and treatment. 2016 Academic Article GET IT
Times cited: 19
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family. 2016 GET IT
Times cited: 11
The future of clinical cancer genomics. Seminars in oncology. 2016 Academic Article GET IT
Times cited: 24
Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group. Journal of genetic counseling. 2016 Academic Article GET IT
Times cited: 12
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 146
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. Cancer discovery. 2016 Academic Article GET IT
Times cited: 42
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature communications. 2016 Academic Article GET IT
Times cited: 65
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. The New England journal of medicine. 2016 Academic Article GET IT
Times cited: 1298
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast cancer research : BCR. 2016 Academic Article GET IT
Times cited: 32
Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nature reviews. Clinical oncology. 2016 Review GET IT
Times cited: 265
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 147
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. American journal of human genetics. 2016 Academic Article GET IT
Times cited: 102
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature communications. 2016 Academic Article GET IT
Times cited: 85
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 194
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 5
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Human molecular genetics. 2016 Academic Article GET IT
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast cancer research : BCR. 2016 Academic Article GET IT
Times cited: 88
Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status. Cancer. 2016 Academic Article GET IT
Times cited: 23
A Germline Variant on Chromosome 4q31.1 Associates with Susceptibility to Developing Colon Cancer Metastasis. PloS one. 2016 Academic Article GET IT
Times cited: 3
Genomic Biomarkers for Breast Cancer Risk. Advances in experimental medicine and biology. 2016 Article GET IT
Times cited: 19
Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes. Urologic oncology. 2015 Academic Article GET IT
Times cited: 15
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertility and sterility. 2015 Academic Article GET IT
Times cited: 24
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 2015 Academic Article GET IT
Times cited: 85
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer. 2015 Academic Article GET IT
Times cited: 17
Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements. PloS one. 2015 Academic Article GET IT
Times cited: 5
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes. Briefings in bioinformatics. 2015 Academic Article GET IT
Times cited: 2
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015 Academic Article GET IT
Times cited: 23
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Human molecular genetics. 2015 Academic Article GET IT
Times cited: 74
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia. PLoS genetics. 2015 Academic Article GET IT
Times cited: 130
An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality. British journal of cancer. 2015 Academic Article GET IT
Times cited: 15
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic oncology. 2015 Information Resource GET IT
Times cited: 11
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast cancer research : BCR. 2015 Academic Article GET IT
Times cited: 30
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015 Academic Article GET IT
Times cited: 409
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. PloS one. 2015 Academic Article GET IT
Times cited: 34
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human molecular genetics. 2015 Academic Article GET IT
Times cited: 38
A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nature communications. 2015 Academic Article GET IT
Times cited: 53
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast cancer research : BCR. 2014 Academic Article GET IT
Times cited: 45
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014 Academic Article GET IT
Times cited: 18
Decade in review--genomics: a decade of discovery in cancer genomics. Nature reviews. Clinical oncology. 2014 Article GET IT
Times cited: 8
Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. American journal of human genetics. 2014 Academic Article GET IT
Times cited: 89
Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma. PloS one. 2014 Academic Article GET IT
Times cited: 21
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment. 2014 Academic Article GET IT
Times cited: 37
Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families. Breast cancer research and treatment. 2014 Academic Article GET IT
Times cited: 6
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS genetics. 2014 Academic Article GET IT
Times cited: 45
Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer. Familial cancer. 2013 Academic Article GET IT
Times cited: 10
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nature genetics. 2013 Academic Article GET IT
Times cited: 261
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS genetics. 2013 Academic Article GET IT
Times cited: 109
Revealing the incidentalome when targeting the tumor genome. JAMA. 2013 Article GET IT
Times cited: 55
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host. Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Academic Article GET IT
Times cited: 9
Assessment of SLX4 Mutations in Hereditary Breast Cancers. PloS one. 2013 Academic Article GET IT
Times cited: 34
Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 48
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genetics in medicine : official journal of the American College of Medical Genetics. 2013 Academic Article GET IT
Times cited: 35
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature genetics. 2013 Academic Article GET IT
Times cited: 466
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS genetics. 2013 Academic Article GET IT
Times cited: 136
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS genetics. 2013 Academic Article GET IT
Times cited: 223
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS genetics. 2013 Academic Article GET IT
Times cited: 97
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?. Breast cancer research and treatment. 2013 Academic Article GET IT
Times cited: 25
Rare variants in XRCC2 as breast cancer susceptibility alleles. Journal of medical genetics. 2012 Academic Article GET IT
Times cited: 34
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast cancer research and treatment. 2012 Academic Article GET IT
Times cited: 2
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PloS one. 2012 Academic Article GET IT
Times cited: 51
Association of a HOXB13 variant with breast cancer. The New England journal of medicine. 2012 Article GET IT
Times cited: 23
Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PloS one. 2012 Academic Article GET IT
Times cited: 8
Genetic testing in gastrointestinal cancers: a case-based approach. Oncology (Williston Park, N.Y.). 2012 Review GET IT
Times cited: 5
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast cancer research : BCR. 2012 Academic Article GET IT
Times cited: 94
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012 Academic Article GET IT
Times cited: 44
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment. 2012 Academic Article GET IT
Times cited: 11
Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resection. Journal of the American College of Surgeons. 2012 Academic Article GET IT
Times cited: 31
What women with breast cancer discuss with clinicians about risk for their adolescent daughters. Journal of psychosocial oncology. 2012 Academic Article GET IT
Times cited: 11
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011 Academic Article GET IT
Times cited: 542
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer. Cancer. 2011 Academic Article GET IT
Times cited: 80
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS biology. 2011 Academic Article GET IT
Times cited: 85
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast cancer research : BCR. 2011 Academic Article GET IT
Times cited: 63
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Human mutation. 2011 Academic Article GET IT
Times cited: 24
Germline mutations in BAP1 predispose to melanocytic tumors. Nature genetics. 2011 Academic Article GET IT
Times cited: 613
Including additional controls from public databases improves the power of a genome-wide association study. Human heredity. 2011 Academic Article GET IT
Times cited: 14
Genetic architecture of prostate cancer in the Ashkenazi Jewish population. British journal of cancer. 2011 Academic Article GET IT
Times cited: 10
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nature medicine. 2011 Academic Article GET IT
Times cited: 151
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer. BJU international. 2011 Academic Article GET IT
Times cited: 42
Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes. Clinical genetics. 2011 Article GET IT
Times cited: 6
Personalized medicine: new genomics, old lessons. Human genetics. 2011 Information Resource GET IT
Times cited: 168
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human genetics. 2011 Academic Article GET IT
Times cited: 15
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer. 2011 Academic Article GET IT
Times cited: 69
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human molecular genetics. 2011 Academic Article GET IT
Times cited: 60
Germline PALB2 mutation analysis in breast-pancreas cancer families. Journal of medical genetics. 2011 Academic Article GET IT
Times cited: 28
Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism: clinical and experimental. 2011 Academic Article GET IT
Times cited: 50
Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 89
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 2010 Academic Article GET IT
Times cited: 38
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer research. 2010 Academic Article GET IT
Times cited: 160
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Academic Article GET IT
Times cited: 99
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS genetics. 2010 Academic Article GET IT
Times cited: 81
Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast cancer research and treatment. 2010 Academic Article GET IT
Times cited: 15
Diagnosing hereditary colorectal cancer. Clinical colorectal cancer. 2010 Review GET IT
Times cited: 11
Genome-wide association studies of cancer predisposition. Hematology/oncology clinics of North America. 2010 Review GET IT
Times cited: 35
New pharmacogenomic paradigm in breast cancer treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Editorial Article GET IT
Times cited: 11
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature genetics. 2010 Academic Article GET IT
Times cited: 271
Genome-wide association studies of cancer: principles and potential utility. Oncology (Williston Park, N.Y.). 2010 Review GET IT
Times cited: 19
Susceptibility loci associated with prostate cancer progression and mortality. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 78
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer prevention research (Philadelphia, Pa.). 2010 Academic Article GET IT
Times cited: 64
Genetic analysis of the early natural history of epithelial ovarian carcinoma. PloS one. 2010 Academic Article GET IT
Times cited: 88
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Breast cancer research and treatment. 2010 Academic Article GET IT
Times cited: 15
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 248
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast cancer research and treatment. 2010 Academic Article GET IT
Times cited: 46
Ethicolegal aspects of cancer genetics. Cancer treatment and research. 2010 Information Resource GET IT
Times cited: 7
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British journal of cancer. 2009 Academic Article GET IT
Times cited: 13
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant. Human mutation. 2009 Academic Article GET IT
Times cited: 30
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. The American journal of surgical pathology. 2009 Academic Article GET IT
Times cited: 123
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 54
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human molecular genetics. 2009 Academic Article GET IT
Times cited: 96
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genetics in medicine : official journal of the American College of Medical Genetics. 2009 Conference Paper GET IT
Times cited: 176
Breast cancer single-nucleotide polymorphisms: statistical significance and clinical utility. Journal of the National Cancer Institute. 2009 Editorial Article GET IT
Times cited: 9
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 55
A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing. The Journal of molecular diagnostics : JMD. 2009 Academic Article GET IT
Times cited: 20
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nature genetics. 2009 Academic Article GET IT
Times cited: 296
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 187
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutation. Mutation research. 2008 Academic Article GET IT
Times cited: 8
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008 Academic Article GET IT
Times cited: 125
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. Journal of the National Cancer Institute. 2008 Academic Article GET IT
Times cited: 184
Ethical and legal implications of cancer genetic testing: do physicians have a duty to warn patients' relatives about possible genetic risks?. Journal of oncology practice. 2008 Academic Article GET IT
Times cited: 19
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer letters. 2008 Academic Article GET IT
Times cited: 18
Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer research. 2008 Academic Article GET IT
Times cited: 95
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proceedings of the National Academy of Sciences of the United States of America. 2008 Academic Article GET IT
Times cited: 268
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 525
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC genetics. 2008 Academic Article GET IT
Times cited: 29
Time to check CHEK2 in families with breast cancer?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Editorial Article GET IT
Times cited: 37
Management of an inherited predisposition to breast cancer. The New England journal of medicine. 2007 Article GET IT
Times cited: 16
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American journal of human genetics. 2007 Academic Article GET IT
Times cited: 216
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007 Academic Article GET IT
Times cited: 477
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies. BMC genetics. 2007 Academic Article GET IT
Times cited: 6
BRCA mutations in women with ductal carcinoma in situ. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 28
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007 Academic Article GET IT
Times cited: 29
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Annals of surgical oncology. 2007 Academic Article GET IT
Times cited: 72
Modeling genetic risk of breast cancer. JAMA. 2007 Editorial Article GET IT
Times cited: 8
Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management. Annals of surgery. 2007 Academic Article GET IT
Times cited: 10
BRCA mutation frequency and penetrance: new data, old debate. Journal of the National Cancer Institute. 2006 Editorial Article GET IT
Times cited: 36
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006 Academic Article GET IT
Times cited: 58
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Information Resource GET IT
Times cited: 166
Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA. 2006 Academic Article GET IT
Times cited: 342
Cancer genetic testing and assisted reproduction. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Information Resource GET IT
Times cited: 83
Increased frequency of disease-causing MYH mutations in colon cancer families. Carcinogenesis. 2006 Academic Article GET IT
Times cited: 35
Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue. Familial cancer. 2006 Academic Article GET IT
Times cited: 13
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer research. 2006 Academic Article GET IT
Times cited: 245
The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 35
Reducing the risk of gynecologic cancer in the Lynch syndrome. The New England journal of medicine. 2006 Editorial Article GET IT
Times cited: 24
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genetic epidemiology. 2006 Academic Article GET IT
Times cited: 14
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. International journal of cancer. 2005 Academic Article GET IT
Times cited: 135
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 366
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer research. 2005 Academic Article GET IT
Times cited: 68
Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. International journal of cancer. 2005 Article GET IT
Times cited: 50
Prevention and management of hereditary breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Information Resource GET IT
Times cited: 134
Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Human molecular genetics. 2005 Academic Article GET IT
Times cited: 88
Hereditary cancer predisposition syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Information Resource GET IT
Times cited: 379
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer. 2005 Academic Article GET IT
Times cited: 116
Evaluation of germline PTEN mutations in endometrial cancer patients. Gynecologic oncology. 2005 Academic Article GET IT
Times cited: 39
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds. Familial cancer. 2005 Academic Article GET IT
Times cited: 23
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. The American journal of surgical pathology. 2005 Academic Article GET IT
Times cited: 124
Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer research. 2004 Academic Article GET IT
Times cited: 99
Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping. Cancer research. 2004 Academic Article GET IT
Times cited: 10
MSH6 mutations in hereditary nonpolyposis colon cancer: another slice of the pie. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Editorial Article GET IT
Times cited: 10
No major association between TGFBR1*6A and prostate cancer. BMC genetics. 2004 Academic Article GET IT
Times cited: 14
Breast MRI for women with hereditary cancer risk. JAMA. 2004 Editorial Article GET IT
Times cited: 35
The genetics of familial lymphomas. Current oncology reports. 2004 Information Resource GET IT
Times cited: 9
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers. Cancer research. 2004 Academic Article GET IT
Times cited: 35
BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 125
Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 100
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Article GET IT
Times cited: 71
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. Journal of medical genetics. 2004 Information Resource GET IT
Times cited: 145
Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. Journal of the National Cancer Institute. 2004 Academic Article GET IT
Times cited: 56
MSH6 germline mutations are rare in colorectal cancer families. International journal of cancer. 2003 Academic Article GET IT
Times cited: 49
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Information Resource GET IT
Times cited: 164
Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. The American journal of surgical pathology. 2003 Academic Article GET IT
Times cited: 176
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast cancer research : BCR. 2003 Academic Article GET IT
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Journal of the National Cancer Institute. 2003 Academic Article GET IT
Times cited: 142
Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients. Leukemia research. 2003 Academic Article GET IT
Times cited: 15
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecologic oncology. 2003 Academic Article GET IT
Times cited: 109
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations. Cancer. 2003 Academic Article GET IT
Times cited: 69
A636P is associated with early-onset colon cancer in Ashkenazi Jews. Journal of the American College of Surgeons. 2003 Academic Article GET IT
Times cited: 23
Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC medical genetics. 2003 Academic Article GET IT
Times cited: 108
BRCA1 and BRCA2 germline mutations in lymphoma patients. Leukemia & lymphoma. 2003 Academic Article GET IT
Times cited: 8
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 2002 Academic Article GET IT
Times cited: 297
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Academic Article GET IT
Times cited: 136
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2002 Academic Article GET IT
Times cited: 127
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Academic Article GET IT
Times cited: 36
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. American journal of human genetics. 2002 Academic Article GET IT
Times cited: 117
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers. Oncogene. 2002 Academic Article GET IT
Times cited: 30
Considerations in genetic counseling for inherited breast cancer predisposition. Seminars in radiation oncology. 2002 Academic Article GET IT
BLM heterozygosity and the risk of colorectal cancer. Science (New York, N.Y.). 2002 Academic Article GET IT
Times cited: 140
Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer. Leukemia & lymphoma. 2002 Academic Article GET IT
Times cited: 21
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 385
Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes, chromosomes & cancer. 2002 Academic Article GET IT
Times cited: 65
Unique de novo mutation of BRCA2 in a woman with early onset breast cancer. Journal of medical genetics. 2002 Article GET IT
Times cited: 22
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proceedings of the National Academy of Sciences of the United States of America. 2002 Academic Article GET IT
Times cited: 74
TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. Type I TbetaR-I(6A) Is a Candidate Tumor Susceptibility Allele. Cancer Res., 58: 2727-2732, 1998. Cancer research. 2001 Article GET IT
Times cited: 11
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2001 Academic Article GET IT
Times cited: 190
Risk of endometrial carcinoma associated with BRCA mutation. Gynecologic oncology. 2001 Academic Article GET IT
Times cited: 127
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer. 2000 Academic Article GET IT
Times cited: 92
The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. American journal of human genetics. 2000 Academic Article GET IT
Times cited: 88
Genetic prognostic markers for colorectal cancer. The New England journal of medicine. 2000 Editorial Article GET IT
Times cited: 26
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. Journal of the National Cancer Institute. 1999 Academic Article GET IT
Times cited: 145
TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer research. 1999 Academic Article GET IT
Times cited: 133
Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes, chromosomes & cancer. 1998 Academic Article GET IT
Times cited: 57
BRCA mutations and survival in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Article GET IT
The APCI1307K allele and breast cancer risk. Nature genetics. 1998 Article GET IT
Times cited: 48
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer research. 1998 Academic Article GET IT
Times cited: 90
Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 1998 Academic Article GET IT
Times cited: 262
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 400
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer research. 1998 Academic Article GET IT
Times cited: 80
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. American journal of human genetics. 1998 Academic Article GET IT
Times cited: 140
Genetic testing for susceptibility to cancer. Task Force on Cancer Genetics Education. JAMA. 1998 Article GET IT
Times cited: 2
BRCA-associated breast cancer in young women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
BRCA-associated breast cancer: absence of a characteristic immunophenotype. Cancer research. 1998 Academic Article GET IT
Times cited: 74
Familial Hodgkin's and non-Hodgkin's lymphoma: different patterns in first-degree relatives. Leukemia & lymphoma. 1997 Academic Article GET IT
Times cited: 14
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA. 1997 Academic Article GET IT
Times cited: 335
Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomatic medicine. 1997 Academic Article GET IT
Times cited: 130
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genetic testing. 1997 Academic Article GET IT
Times cited: 42
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature medicine. 1996 Review GET IT
Times cited: 264
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature genetics. 1996 Academic Article GET IT
Times cited: 314
Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet (London, England). 1996 Academic Article GET IT
Times cited: 121
Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature genetics. 1996 Academic Article GET IT
Times cited: 151
Tobacco control: reducing cancer incidence and saving lives. American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Breast cancer and BRCA1 mutations. The New England journal of medicine. 1996 Article GET IT
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature genetics. 1996 Academic Article GET IT
Times cited: 244
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature genetics. 1996 Academic Article GET IT
Times cited: 684
BRCA1. A new marker in the management of patients with breast cancer?. Cancer. 1996 Editorial Article GET IT
Times cited: 2
Funding for clinical (patient-oriented) oncology research: current status and recommendations for improvement. American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. American journal of human genetics. 1996 Academic Article GET IT
Times cited: 231
BCL-6 in diffuse large-cell lymphomas. Important advances in oncology. 1996 Information Resource GET IT
Times cited: 20
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 1996 Academic Article GET IT
Times cited: 189
BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma. Leukemia & lymphoma. 1995 Academic Article GET IT
Times cited: 31
p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood. 1995 Academic Article GET IT
Times cited: 132
Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood. 1995 Academic Article GET IT
Times cited: 36
BCL-6 protein is expressed in germinal-center B cells. Blood. 1995 Academic Article GET IT
Times cited: 478
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA. 1995 Academic Article GET IT
Times cited: 405
The advantage of rearranging bcl-6. The New England journal of medicine. 1994 Article GET IT
Quantitating familial cancer risk: a resource for clinical oncologists. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Information Resource GET IT
Times cited: 95
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. The New England journal of medicine. 1994 Academic Article GET IT
Times cited: 331
Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood. 1994 Academic Article GET IT
Times cited: 68
p53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993 Academic Article GET IT
Times cited: 331
6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood. 1993 Academic Article GET IT
Times cited: 169
Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. Genes, chromosomes & cancer. 1993 Academic Article GET IT
Times cited: 47
t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood. 1992 Academic Article GET IT
Times cited: 102
Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood. 1992 Academic Article GET IT
Times cited: 22
Variant t(8;14) translocations in non-Burkitt's non-Hodgkin's lymphomas. Blood. 1992 Article GET IT
Times cited: 6
Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations. Hematology/oncology clinics of North America. 1991 Information Resource GET IT
Times cited: 62
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes, chromosomes & cancer. 1991 Academic Article GET IT
Times cited: 168
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood. 1991 Academic Article GET IT
Times cited: 191
MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood. 1991 Academic Article GET IT
Times cited: 109
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. The American journal of medicine. 1991 Academic Article GET IT
Times cited: 41
Molecular structure of double reciprocal translocations: significance in B-cell lymphomagenesis. Oncogene. 1991 Academic Article GET IT
Times cited: 12
Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia. 1990 Academic Article GET IT
Times cited: 41
Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes, chromosomes & cancer. 1990 Academic Article GET IT
Times cited: 48
Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood. 1990 Academic Article GET IT
Times cited: 86
Cytogenetic and molecular genetic analysis of abnormal cells in Hodgkin's disease. Cancer genetics and cytogenetics. 1989 Academic Article GET IT
Times cited: 24
t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma. Blood. 1989 Academic Article GET IT
Times cited: 101
Leukemic differentiation of a mediastinal germ cell tumor. 1989 GET IT
Times cited: 105
Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13. Oncogene. 1989 Academic Article GET IT
Times cited: 42
Molecular analysis of structural chromosome changes affecting chromosome band 11q23. Disease markers. 1989 Academic Article GET IT
Times cited: 3
18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance. British journal of haematology. 1989 Academic Article GET IT
Times cited: 74
Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma. Cancer genetics and cytogenetics. 1989 Academic Article GET IT
Times cited: 20
Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood. 1987 Academic Article GET IT
Times cited: 88

more ...

less ...

Background

education and training

M.D., Harvard Medical School 1982
M.P.H., Harvard School of Public Health 1982
A.B., Princeton University 1977

Contact

full name

Kenneth Offit

primary email

[email protected]

VIVO Weill Cornell Medical College

Kenneth Offit Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email